Publicaciones en colaboración con investigadores/as de Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (16)

2024

  1. Precision nutrition impact on metabolic health and quality of life in aging population after a 3-month intervention: A randomized intervention

    Journal of Nutrition, Health and Aging, Vol. 28, Núm. 7

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

    Molecular Aspects of Medicine, Vol. 93

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides

    JACC: Heart Failure, Vol. 11, Núm. 1, pp. 58-72

  5. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

    Cancers, Vol. 14, Núm. 12

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer

    Molecular Oncology, Vol. 15, Núm. 2, pp. 350-363

2020

  1. Epigenetic loss of the transfer RNA-modifying enzyme TYW2 induces ribosome frameshifts in colon cancer

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 34, pp. 20785-20793

  2. Myocardial interstitial fibrosis in the era of precision medicine. Biomarker-based phenotyping for a personalized treatment

    Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 248-254

2019

  1. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase i clinical trials comparing intradermal and intranodal cell administration

    BMJ Open, Vol. 9, Núm. 9

2017

  1. Preclinical Safety Evaluation of Allogeneic Induced Pluripotent Stem Cell-Based Therapy in a Swine Model of Myocardial Infarction

    Tissue Engineering - Part C: Methods, Vol. 23, Núm. 11, pp. 736-744

2014

  1. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival

    International Journal of Cancer, Vol. 135, Núm. 3, pp. 598-610

2012

  1. Dendritic cells: Nearly 40 years later

    Inmunologia